Skip to main content

AlphaHelix Merges with Techtum Lab

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swedish firms AlphaHelix Molecular Diagnostics and Techtum Lab have merged in an all-stock deal.

Under the terms of the deal, AlphaHelix will issue about 29.4 million shares of its stock at a price of SEK6.8 million ($1 million) to Labkompaniet, which owned Techtum. After the deal is completed, Labkompaniet will own a little less than 64 percent of the new company and shareholders of AlphaHelix will own the balance.

In a statement, AlphaHelix said that the deal provides it with a "complete marketing and sales organization" built upon 20 years of selling qPCR products in Scandinavia.

Techtum Lab sells PCR instruments and consumables. AlphaHelix develops and markets qPCR instruments.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.